Your session is about to expire
← Back to Search
Neurostimulation
Transcranial Direct Current Stimulation for Ringing in the Ears (MRI HDtES-T Trial)
N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week, 2 weeks, 1 month
Summary
This trial is testing a gentle brain stimulation technique called HDtES on adults who have chronic ringing in their ears. The treatment uses small electrodes to send a mild electrical current through the scalp, aiming to change brain activity and connections. Researchers will measure changes in brain function and tinnitus symptoms over time. High-definition transcranial direct current stimulation (HD-tDCS) has been explored in previous studies for its potential to modulate brain activity and improve auditory processing in tinnitus patients.
Eligible Conditions
- Ringing in the Ears
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week, 2 weeks, 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week, 2 weeks, 1 month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in brain functional connectivity.
Secondary study objectives
Changes in tinnitus symptoms
Side effects data
From 2021 Phase 2 & 3 trial • 160 Patients • NCT024834682%
skin irritation
2%
Car accident
100%
80%
60%
40%
20%
0%
Study treatment Arm
tDCS (Active)
tDCS (Sham)
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ActiveExperimental Treatment1 Intervention
Group II: ShamPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Direct Current Stimulation
2014
Completed Phase 3
~1100
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,645 Previous Clinical Trials
958,574 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger